Literature DB >> 10516709

Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement.

I Tezcan1, O Sanal, F Ersoy, D Uckan, S Kiliç, A Metin, M Cetin, R Akin, C Oner, A Tuncer.   

Abstract

Griscelli disease (GD) is a rare disorder characterized by pigment dilution, immunodeficiency and occurrence of accelerated phase consisting of hemophagocytosis, pancytopenia and neurological manifestations. Allogeneic BMT in the early period is an important modality of treatment for GD. We carried out an alloBMT from an HLA-identical sibling donor on a 4-year-old girl who presented in accelerated phase with neurological manifestations including convulsions, strabismus, severe dysarthria, ataxia and clonus. She was treated with etoposide, methylprednisolone and intrathecal methotrexate for 8 weeks and underwent alloBMT after receiving a conditioning regimen including ATG (rabbit, 10 mg/kg x 5 days), Bu/Cy. 8 x 108/kg nucleated bone marrow cells were given. Engraftment occurred early and the post-BMT period was uneventful. Currently, she is at 18 months post BMT with sustained engraftment and with a normal neurological examination except for minimal clonus. Long-term follow-up will determine the prognosis regarding the neurological findings.

Entities:  

Mesh:

Year:  1999        PMID: 10516709     DOI: 10.1038/sj.bmt.1702007

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Griscelli syndrome types 1 and 3: analysis of four new cases and long-term evaluation of previously diagnosed patients.

Authors:  Deniz Cağdaş; Tuba Turul Ozgür; Gülten Türkkanı Asal; Ilhan Tezcan; Ayşe Metin; Nathalie Lambert; Geneiveve de Saint Basile; Ozden Sanal
Journal:  Eur J Pediatr       Date:  2012-06-19       Impact factor: 3.183

2.  Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.

Authors:  M Al-Mofareh; M Ayas; A Al-Seraihy; K Siddiqui; A Al-Jefri; I Ghemlas; H Alsaedi; H El-Solh; S Al-Sweedan; B Al-Saud; H Al-Mousa; H Al-Dhekri; R Arnaout; R Mohammed; S Al-Muhsen; A Al-Ahmari
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

3.  Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity.

Authors:  Ozden Sanal; Fúgen Ersoy; Ilhan Tezcan; Ayşe Metin; Leman Yel; Gaël Ménasché; Aytemiz Gürgey; Izzet Berkel; Geneviève de Saint Basile
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

4.  Griscelli syndrome: characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene.

Authors:  João C S Bizario; Jérôme Feldmann; Fabíola A Castro; Gaël Ménasché; Cristina M A Jacob; L Cristofani; Erasmo B Casella; Júlio C Voltarelli; Geneviève de Saint-Basile; Enilza M Espreafico
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

Review 5.  Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies.

Authors:  Jong Jin Seo
Journal:  Blood Res       Date:  2015-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.